These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15351840)

  • 1. Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration.
    Pyo RT; Sato Y; Mackman N; Taubman MB
    Thromb Haemost; 2004 Sep; 92(3):451-8. PubMed ID: 15351840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of smooth muscle derived tissue factor in mediating thrombosis and arterial injury.
    Taubman MB; Wang L; Miller C
    Thromb Res; 2008; 122 Suppl 1():S78-81. PubMed ID: 18691507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
    Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
    J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.
    Qi W; Li Q; Liew CW; Rask-Madsen C; Lockhart SM; Rasmussen LM; Xia Y; Wang X; Khamaisi M; Croce K; King GL
    Diabetologia; 2017 Mar; 60(3):585-596. PubMed ID: 27933336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor.
    Ott I; Michaelis C; Schuermann M; Steppich B; Seitz I; Dewerchin M; Zohlnhofer D; Wessely R; Rudelius M; Schömig A; Carmeliet P
    Circ Res; 2005 Aug; 97(3):293-8. PubMed ID: 16020755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty.
    Nili N; Cheema AN; Giordano FJ; Barolet AW; Babaei S; Hickey R; Eskandarian MR; Smeets M; Butany J; Pasterkamp G; Strauss BH
    Am J Pathol; 2003 Sep; 163(3):869-78. PubMed ID: 12937128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing mitochondrial fission diminishes vascular smooth muscle cell migration and ameliorates intimal hyperplasia.
    Wang L; Yu T; Lee H; O'Brien DK; Sesaki H; Yoon Y
    Cardiovasc Res; 2015 May; 106(2):272-83. PubMed ID: 25587046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury.
    Liu P; Patil S; Rojas M; Fong AM; Smyth SS; Patel DD
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2056-62. PubMed ID: 16809547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
    Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF7L2 (Transcription Factor 7-Like 2) Regulation of GATA6 (GATA-Binding Protein 6)-Dependent and -Independent Vascular Smooth Muscle Cell Plasticity and Intimal Hyperplasia.
    Srivastava R; Rolyan H; Xie Y; Li N; Bhat N; Hong L; Esteghamat F; Adeniran A; Geirsson A; Zhang J; Ge G; Nobrega M; Martin KA; Mani A
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):250-262. PubMed ID: 30567484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein expression and intimal hyperplasia after arterial injury: a role for Galpha(i) proteins.
    Davies MG; Mason DP; Tran PK; Deou J; Hawkins S; Clowes AW
    J Vasc Surg; 2001 Feb; 33(2):408-18. PubMed ID: 11174797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of the effect and mechanism of vascular intimal hyperplasia in Tiam1 knockout mice.
    Kou W; Xu X; Ji S; Chen M; Liu D; Wang K; Zhuang J; Yu Q; Zhao Q; Xu Y; Zhang H; Peng W
    Biochem Biophys Res Commun; 2018 Feb; 497(1):248-255. PubMed ID: 29432743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the procoagulant response to arterial injury.
    Taubman MB; Giesen PL; Schecter AD; Nemerson Y
    Thromb Haemost; 1999 Aug; 82(2):801-5. PubMed ID: 10605785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease.
    Shimizu K; Minami M; Shubiki R; Lopez-Ilasaca M; MacFarlane L; Asami Y; Li Y; Mitchell RN; Libby P
    Circulation; 2009 Nov; 120(18):1800-13. PubMed ID: 19841301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intimal hyperplasia in murine aortic allografts by the oral administration of the transforming growth factor-beta receptor I kinase inhibitor SD-208.
    Sun Y; Ye P; Wu J; Liu Z; Zhang A; Ren L; Cheng C; Huang X; Wang K; Deng P; Wu C; Yue Z; Xia J
    J Heart Lung Transplant; 2014 Jun; 33(6):654-61. PubMed ID: 24685405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
    Resch ZT; Simari RD; Conover CA
    Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice.
    Choi ET; Khan MF; Leidenfrost JE; Collins ET; Boc KP; Villa BR; Novack DV; Parks WC; Abendschein DR
    Circulation; 2004 Mar; 109(12):1564-9. PubMed ID: 15007005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.